The Fisher Center for Alzheimer's Research Foundation primarily funds the research of Nobel laureate Dr. Paul Greengard. Dr. Greengard and his team of scientists have recently developed new technologies that will accelerate the pace of future Alzheimer's research. Based on these new findings, we have doubled our funding commitment this year to support the promising new research initiatives that are now possible.
35 million people worldwide have Alzheimer’s disease
5.3 million Americans have Alzheimer's
Every 70 seconds someone in America develops Alzheimer’s disease
Alzheimer's, now the fifth leading killer, rose 47% from 2000 to 2006
54% of the U.S. population has been touched in some way by Alzheimer's
Presently, there is no cure for Alzheimer’s disease
Alzheimer's Disease Cause, Care, & Cure
The Fisher Center for Alzheimer’s Research Foundation serves people with Alzheimer's and their families by funding research to understand the causes of, find a cure for, and improve the quality of life for people with this devastating disease. We are committed to making Alzheimer's disease nothing but a memory.
Our team of internationally renowned scientists, under the direction of Nobel laureate Dr. Paul Greengard, has been at the forefront of seminal research that has provided a conceptual framework for modern day investigations into Alzheimer's disease. Our groundbreaking research is the key to finding a cure for Alzheimer's by advancing truly effective therapies that arrest its development or prevent the illness altogether.
Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer's Disease Research at The Rockefeller University
Apathy a Common Problem in Alzheimer’s Fri, January 29, 2010 12:12:00 PM EST Most people think of memory loss when they think of Alzheimer’s. But the disease can cause a wide range of behavioral and personality changes as well... Read More
F.D.A. Approves New Generic Form of Aricept Wed, January 27, 2010 12:50:00 PM EST Aricept, the widely prescribed drug for early to middle stages Alzheimer’s disease, is now available in a generic form that dissolves on the tongue, after the Food and Drug Administration approved the generic drug for sale in the United States... Read More
Fat Hormone Leptin Linked to Alzheimer’s Wed, January 27, 2010 1:17:00 PM EST Older men and women with high levels of leptin, a hormone made by fat cells and linked to appetite regulation, may have a reduced risk of developing Alzheimer’s disease compared to those with low levels of the hormone, a new study reports. Read More
Imaging Test May Predict Progression to Alzheimer’s Wed, January 27, 2010 1:54:00 PM EST An imaging agent called Pittsburgh compound B may allow doctors to detect Alzheimer’s at very early stages, before memory loss and other symptoms become evident... Read More
This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging,
Department of Health and Human Services, Washington, D.C. 20201.
Grantees undertaking projects under government sponsorship are
encouraged to express freely their findings and conclusions. Points of
view or opinions do not, therefore, necessarily represent official Administration on Aging policy.
